Susceptibility of natural killer (NK) cells to reactive oxygen species (ROS) and their restoration by the mimics of superoxide dismutase (SOD)

被引:38
作者
Nakamura, K
Matsunaga, K
机构
[1] Kitasato Univ, Sch Med, Dept Biochem, Mol Biol Lab, Sagamihara, Kanagawa 228, Japan
[2] Kureha Chem Ind Co Ltd, Biomed Res Lab, Tokyo, Japan
关键词
NK cell; LGL; cancer-bearing rat; reactive oxygen species; oxidative stress; SOD mimics;
D O I
10.1089/cbr.1998.13.275
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Natural killer (NK) cells are susceptible to reactive oxygen species (ROS), and lose the activity by the effects of ROS. Cancer bearing hosts usually suffer from oxidative stress (OS), and the NK-activity decreases to a significantly lower level than normal controls. Superoxide dismutase (SOD)-mimicking substances, such as protein-bound polysaccharide of Coriolus versicolor (Fr) QUEL (PSK) and iron-chelating chlorin e6-Na (FeCNa), can restore the NK-activity of cancer bearing hosts, when collaborating with catalase. Incorporation of H-3-thymidine by ROS-treated NK-cells is not affected, indicating that these cells are still active in the nucleic acid metabolism. Intraperitoneal administration of anti-Asialo GM1 antibody extinguished the NK-activity. NK-cells affected by ROS lost the adherence to target cancer cells in both in vitro and in vivo. ROS may change the surface charge of NK-cells to anionic, resulting in an inability of adhesion to target cancer cells which usually show the negative surface charge.
引用
收藏
页码:275 / 290
页数:16
相关论文
共 35 条
  • [1] BALL SS, FREE RADICALS AGING, P427
  • [2] BARLOZZARI T, 1983, J IMMUNOL, V131, P1024
  • [3] ENZYME DEFENSE AGAINST REACTIVE OXYGEN DERIVATIVES .2. ERYTHROCYTES AND TUMOR-CELLS
    BOZZI, A
    MAVELLI, I
    FINAZZIAGRO, A
    STROM, R
    WOLF, AM
    MONDOVI, B
    ROTILIO, G
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 1976, 10 (01) : 11 - 16
  • [4] SUPEROXIDE RADICALS AND HYDROGEN-PEROXIDE FORMATION IN MITOCHONDRIA FROM NORMAL AND NEOPLASTIC TISSUES
    DIONISI, O
    GALEOTTI, T
    TERRANOVA, T
    AZZI, A
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1975, 403 (02) : 292 - 300
  • [5] GOTO T, 1983, J IMMUNOL, V130, P1350
  • [6] HABU S, 1981, J IMMUNOL, V127, P34
  • [7] HANSBROUGH JF, 1979, SURG FORUM, V30, P313
  • [8] HANSSON M, 1996, J IMMUNOL, V156, P41
  • [9] HAUSER GJ, 1990, CANCER RES, V50, P3503
  • [10] Hodge JE, 1962, METHODS CARBOHYDRATE, V1, P338